Avalyn Pharma Appoints Lyn Baranowski Chief Executive Officer
Copyright 2022, Business Wire.
news
2022-10-17 12:00:00

October 17, 2022 08:00 AM Eastern Daylight Time SEATTLE--(BUSINESS WIRE)--Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases, announced the appointment of Lyn Baranowski as chief executive officer. Ms. Baranowski brings more than two decades of experience leading a vast array of functions in biotech, big pharma and venture capital firms.



'My colleagues and I would like to express our gratitude to Dr.
